For the oncolytic measles virus MV-NIS used in this study, a trial testing the combination with PD-1/PD-L1 blockade with atezolizumab in small cell lung cancer was initiated, but terminated due to low recruitment (NCT02919449). This evidence concerns the gene PDCD1 and small cell lung carcinoma.